Search

A new study on prostate cancer conducted by the Aichi Cancer Center in Nagoya, Japan, explores the clinical efficacy and openness to new challenges of low dose rate (LDR) brachytherapy for prostate cancer. LDR brachytherapy has been widely used in Japan and other parts of the world, demonstrating beneficial clinical outcomes for intermediate-to-high-risk prostate cancer. The study highlights the advancements in LDR brachytherapy techniques and the combined use of this treatment with other modalities for better treatment efficacy. The researchers also discuss the applications of LDR brachytherapy in various clinical settings and highlight technologies under development. [Extracted from the article]